Beneficial effects of rosiglitazone on novel cardiovascular risk factors in patients with Type 2 diabetes mellitus

N. P. E. Kadoglou, F. Iliadis, N. Angelopoulou, D. Perrea, C. D. Liapis and M. Alevizos

Diabetic Medicine 25 ( 3 ): 333 - 340 , 2008